Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study (Q51813816)

13 April 2018

title

Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study (English)

1 reference

DOI

https://api.crossref.org/works/10.1007/S00415-011-5927-Y

24 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21327852

24 November 2024

Kazumasa Kume

1 reference

13 April 2018

Haruo Hanyu

1 reference

13 April 2018

Tomohiko Sato

1 reference

13 April 2018

Kentaro Hirao

1 reference

13 April 2018

Soichiro Shimizu

1 reference

13 April 2018

Hidekazu Kanetaka

1 reference

13 April 2018

Hiofumi Sakurai

1 reference

13 April 2018

Toshihiko Iwamoto

1 reference

13 April 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21327852

24 November 2024

publication date

17 February 2011

1 reference

13 April 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00415-011-5927-y.pdf

1 reference

https://api.crossref.org/works/10.1007/S00415-011-5927-Y

http://link.springer.com/article/10.1007/s00415-011-5927-y/fulltext.html

24 November 2024

1 reference

https://api.crossref.org/works/10.1007/S00415-011-5927-Y

http://link.springer.com/content/pdf/10.1007/s00415-011-5927-y

24 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S00415-011-5927-Y

24 November 2024

1 reference

13 April 2018

volume

258

1 reference

13 April 2018

issue

1 reference

13 April 2018

page(s)

1295-1303

1 reference

13 April 2018

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Alzheimer's disease and medical disease conditions: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Cholesterol and APOE genotype interact to influence Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Contribution of vascular risk factors to the progression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Vascular factors predict rate of progression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Relationship of vascular risk to the progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Cardiovascular disease risk factors and progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-5927-Y

Anatomic standardization: linear scaling and nonlinear warping of functional brain images.

21 January 2018

1 reference

12 December 2020

15-year longitudinal study of blood pressure and dementia

1 reference

12 December 2020

Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

1 reference

12 December 2020

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET

1 reference

12 December 2020

No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease

1 reference

12 December 2020

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

12 December 2020

Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis.

1 reference

12 December 2020

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018